Caregen's latest marketcap:
As of 08/02/2025, Caregen's market capitalization has reached $1.64 B. According to our data, Caregen is the 7184th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.64 B |
| Revenue (ttm) | 60.07 M |
| Net Income (ttm) | 22.48 M |
| Shares Out | 48.87 M |
| EPS (ttm) | 0.46 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 06/27/2025 |
| Earnings Date | 08/07/2025 |
Caregen's yearly market capitalization.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/02/2025 | ₩2.28 T | $1.64 B | 74.56% | 7184 |
| 12/30/2024 | ₩1.41 T | $945.39 M | 4.43% | 9112 |
| 12/28/2023 | ₩1.35 T | $1.04 B | 0.3% | 8435 |
| 12/29/2022 | ₩1.35 T | $1.06 B | 106.59% | 7955 |
| 12/30/2021 | ₩652.09 B | $547.76 M | -7.25% | 12745 |
| 12/30/2020 | ₩703.08 B | $646.84 M | -10.21% | 10205 |
| 03/14/2019 | ₩783 B | $673.38 M | 7.9% | 8573 |
| 12/28/2018 | ₩725.68 B | $645.86 M | -17.27% | 7838 |
| 12/28/2017 | ₩877.16 B | $815.76 M | -0.24% | 8074 |
| 12/29/2016 | ₩879.29 B | $721.02 M | -19.51% | 7951 |
Company Profile
About Caregen Co., Ltd.
Caregen Co., Ltd. is a biotechnology company specializing in the research, development, and commercialization of biomimetic peptides worldwide. Founded in 2001 and headquartered in Anyang-Si, South Korea, the company focuses on innovative solutions in skincare, medical treatments, and health products.
Product Portfolio
- Filler Products: REVOFIL, DR.CYJ, PROSTROLANE, PROSTROLANE B-Series, CG Styler 600
- Skincare Products: Dermaheal, PURILUX Whitening, Pim-Pim-Paul, Neovert
- Scalp Care Products: Renokin, Pelo Baum
- Healthy Foods: proGsterol
Research & Development
Caregen is actively developing treatments and solutions for a wide range of medical and cosmetic needs, including:
- Medical Treatments: COVID-19, macular degeneration, diabetic retinopathy, arthritis, and more.
- Medical Equipment: Facial beauty, scalp/hair improvement, body care.
- Cosmetics: Wrinkle improvement, whitening, acne care, UV protection, and others.
- Health Foods: Blood sugar control, liver function improvement, cholesterol management.
With a commitment to innovation, Caregen continues to expand its portfolio to address diverse health and beauty needs globally.
Frequently Asked Questions
-
What is Caregen's (KOSDAQ-214370) current market cap?As of 08/02/2025, Caregen (including the parent company, if applicable) has an estimated market capitalization of $1.64 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Caregen (KOSDAQ-214370) rank globally by market cap?Caregen global market capitalization ranking is approximately 7184 as of 08/02/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.